儿童静脉血栓栓塞症中的生物标志物:一项系统文献综述
该系统综述检索1990至2022年同行评议文献,纳入40项研究共10987名29天至18岁患儿,评估生物标志物对静脉血栓栓塞症(VTE)及其并发症的预测价值。白蛋白、C反应蛋白、D-二聚体、因子VIII和凝血酶-抗凝血酶复合物在VTE预测中显示出前景,但研究间差异大、偏倚风险高,尚无生物标志物能一致预测血栓后综合征、VTE持续或复发。
要点
- 40项研究共10987名患儿,中位年龄4.7岁,评估46种生物标志物对VTE的预测价值。
- 白蛋白、C反应蛋白、D-二聚体、因子VIII和凝血酶-抗凝血酶复合物在儿童VTE预测中显示出前景。
- 9项研究共1606名患儿中,无生物标志物能一致预测血栓后综合征、VTE持续或复发。
核心结论
- 多种候选生物标志物在儿童VTE预测中显示出前景,但研究间差异和现有文献的高偏倚风险阻碍其广泛用于临床。
- 需要在不同儿科亚群中进一步开展前瞻性研究。
研究设计与样本
- 系统文献综述,检索1990至2022年同行评议文献,纳入评估29天至18岁患者使用生物标志物预测VTE或其并发症的研究。
- 因研究设计、人群和结局异质性大,未进行定量数据合成。
- 共纳入40项研究,合计10987名参与者,中位年龄4.7岁。
主要发现
- 报告常缺乏关键方法学数据,包括采血方法(68%的研究)、采血时间点、实验室检测技术(41%)或主要结局定义(20%)。
- 32项研究共9525名参与者评估了46种个体生物标志物对VTE的预测价值,包括D-二聚体、纤维蛋白原、血小板计数、白细胞计数和因子VIII。
- 白蛋白、C反应蛋白、D-二聚体、因子VIII和凝血酶-抗凝血酶复合物水平在VTE预测中显示出前景。
- 9项研究共1606名参与者中,无生物标志物能一致预测儿童血栓后综合征、VTE持续或VTE复发。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 报告常缺乏关键方法学数据,包括采血方法(68%的研究)和采血时间点、实验室检测技术(41%)或主要结局定义(20%)。
- 不同研究之间存在差异,且现有文献存在高偏倚风险。
- 需要在不同儿科亚群中进一步开展前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accurate prediction of the individual risk of venous thromboembolism (VTE) remains suboptimal in children, and biomarkers are currently not used to stratify the risk of VTE in children. OBJECTIVES: This study aimed to assess which biological or radiological biomarkers may predict VTE or VTE complications in children. PATIENTS/METHODS: A literature search was performed for peer-reviewed publications (1990-2022). We included studies addressing the use of biomarkers for patients aged 29 days to 18 years to predict VTE or its complications, including but not limited to TE-related death, VTE recurrence, or postthrombotic syndrome. Given the heterogeneity of the study designs, populations, and outcomes, no quantitative data synthesis was performed. RESULTS: Forty studies were included, totaling 10,987 participants (median age: 4.7 years). Reports were often lacking critical methodological data, including blood collection method (68% of studies) and timepoints, laboratory testing technique (41%), or primary outcome definition (20%). Forty-six individual biomarkers were assessed for VTE prediction (32 studies, 9525 participants), including d-dimers, fibrinogen, platelet count, white blood cell count, and factor VIII. Albumin, C-reactive protein, d-dimers, factor VIII, and thrombin-antithrombin levels showed promising results for VTE prediction. In 9 studies (1606 participants), no biomarker was consistently predictive of postthrombotic syndrome, VTE persistence, or VTE recurrence in children. CONCLUSIONS: Several candidate biomarkers were promising in the prediction of VTE in children. Still, discrepancies between different studies and the high risk of bias from the current literature prevent their widespread use in the clinical setting. Further prospective research in various pediatric subpopulations is required.
引用
- Pelland-Marcotte MC, Bouchard V, Bégin E, et al. Biomarkers in pediatric venous thromboembolism: a systematic review of the literature. J Thromb Haemost. 2023. PMID: 36958517. doi:10.1016/j.jtha.2023.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。